About Us

Ascot Science is a global Clinical Research Organization, founded in 2016 in Istanbul by Dr. Aslıgül Kendirci, an internationally recognized clinical research scientist in the pharma industry.

A creative, user-centric, and solution-focused global consultancy, the Ascot Science offers clinical research training and design, globally informed and locally actionable state of the art consulting to the pharmaceutical industry and other stakeholders across the Turkish, Middle-East, Africa, and international pharmaceutical innovation ecosystem.

Ascot Science is a Clinical Research Organization based in Istanbul focusing on pharmaceutical companies, medical departments, clinical trials departments, regulatory authorities, and patient advocacy groups in Turkey, Middle East, and North Africa.

We provide full-service solutions for Phase I-IV and Post Marketing Observational Studies . Ascot Science offers One Stop Shop in a One Contact opportunities their clients and work with Challenge Accepted Approach

Are You Looking For a CRO That is an Invested In Your Trials’ Success As You Are?

We aim to be recognized as the best-in-class partner for clinical research services and to achieve it, we operate within the industry’s highest medical, scientific and regulatory standards with uncompromising integrity and ethics, respect for employees, clinical trial participants, investigators, suppliers, and the community.

Ascot Science has established a solid network of close relationships and collaborations with numerous sites and investigators, therefore we are able to support sponsors while selecting and then connecting to the most suitable locations for your trial with the smoothest recruitment potential for almost any therapeutic indication.

  • Oncology
  • Hematology
  • Infectious Diseases
  • Respiratory
  • CNS
  • Psychiatry
  • Gastroenterology
  • Immune Diseases
  • Women Health
  • Cardiology
  • Endocrinology
  • Rheumatology
  • Transplantation
  • Nephrology
  • Vaccines
Our Leadership Team

Aslıgül Kendirci, PhD Pharm.

President & Founder

Dr. Aslıgül Kendirci is a scholar and business executive in biotechnology and pharmaceutical
discovery and clinical development with strong acumen on product development including regulatory
science. science. science. science. science. She has over 25 years of experience in the industry
and She has successfully contributed to and led the global multi-country development of including,
for example, at Roche, Abbott and Bayer Pharmaceuticals. She has also served as the Head of
Pharmaceutical Technology Department at İstinye University in İstanbul.

Dr. Kendirci is an internationally recognized leader in the biotechnology and clinical trials,
particularly in clinical research regarding oncology and cancer therapeutics innovation,
antimicrobials and infectious diseases, and CRO management. She has deep expertise in medical,
regulatory and clinical research in the pharmaceutical and the biotechnology sectors in Turkey as
well as the US and the Middle East, and Africa. She was an active lecturer at Roche Clinical
Trials School for 10 years in Turkey and the Middle East and Africa where she was instrumental in
launching the School.

Dr. Kendirci has most recently founded the Ascot Science after having been a Clinical Development
Director at Roche Pharmaceuticals, as Head of Turkey, the Middle East, and Africa. She established
the first product development department in Turkey and made Turkey a hub country for Middle East
Africa region in 2009.

Prior to Roche, she was Clinical Research Manager in Abbot Laboratories Turkey and the US. Prior
to Abbot, Dr. Kendirci worked in Bayer as Clinical Project Manager, Clinical Research Associate as
well as Regulatory Affairs Executive.

Dr. Kendirci holds a Ph.D. in Pharmaceutical Technology from the Ege University Pharmacy Faculty
and a Diploma from the First International Advanced Course on Technology and Control of Drugs at
the Italian Ministry of Health. She has contributed to peer-reviewed medical literature on
pharmacovigilance and pharmaceutical innovation and continues to serve as a visiting lecturer at
Istinye University, Pharmacy Faculty. Additionally, she is a Member of the Board of Trustees at
Partners For Patients, a Patient Advocacy Research Organization where she is President and CEO of
the Middle East & Africa.